省级主体功能区规划实施评价

主体功能区规划是指导国土空间开发的宏观和战略性规划。随着规划进入实施阶段,实施评价研究亟待展开。以省级主体功能区规划为对象设计了总体框架,探讨了结果—过程评价相结合的规划实施评价指标设计思路,分别从规划目标实现程度、分区功能落实情况、规划实施保障机制和规划社会影响评价4个方面,选择31个具有代表性的指标确定了规划实施评价的指标体系,并对主体功能区规划实施评价指标权重确定、指标标准化、评价方法等进行了探讨。     

教育生态学视阈下的高职专业形态建设研究

高职专业建设或可被视为一个相对独立、开放的生态系统,用教育生态学的理论和方法予以研究.杭州职业技术学院专业建设就是其中的一个绝佳范例,或可说明构建职院校专业形态建设的生态模型的可行性.     

Core Requirements for the Economics Major

In this article, the authors are the first to describe the core economics curriculum requirements for economics majors at all American colleges and universities, as opposed to a sample of institutions. Not surprisingly, principles of economics is nearly universally required and implemented as a two-semester course in 85 percent of economics major programs. Most schools do not prescribe the order in which the principles sequence is taken. The intermediate courses are commonly required, although variation exists across institution types. While the quantitative requirement for the major has increased since 1980, significant differences exist among institutions and by academic rankings. As compared to 1950, there has been an increase in the number of required economics credit hours for the major.     

地方人大重大事项决定权工作机制探索

党的十八大对坚持和完善人民代表大会制度提出了新的更高要求,十八届三中全会作出的《中共中央关于全面深化改革若干重大问题的决定》,特别明确了人大重大事项决定权。鉴于目前地方人大及其常委会的决定权基本虚置的状况,本文探讨了地方人大重大事项决定权的涵义及工作机制,以期健全人大讨论、决定重大事项制度,推进人民代表大会制度理论和实践创新。     

高职营销专业实训教学模式探索与实践

为了弥补高职营销专业的学生在专业学习过程中社会实践的不足,教师可以通过科学实用的案例任务的设计和开放式的小组合作学习方式的有机组合,开展课程实训,培养提升学生综合职业能力,提高教学效果和效率。     

重大建设工程移民安置的社会福利分析——从土地价值角度出发

为了探讨基于土地价值的重大建设项目工程移民社会福利的变化,采用马克思的地租理论和实地走访调查的方式,测算土地价值,运用社会剩余表达移民和安置区原居民的社会福利,结合丹江口水库汉南移民的实际情况,得出结论:工程移民降低了移民和安置区原居民的社会福利;未遵守完全补偿和兼顾公平与效率的原则。基于这样的结果,最后提出:补偿方案应严格执行移民补偿标准、提高工程移民信息透明度和福利相关方参与度的建议。     

翻译专业本科阶段口译能力发展的现状及途径

本科阶段的口译翻译训练应有意识地培养学生进行双语转换思维的模式,高校应从课程设置、师资力量以及口译能力的课外练习三个方面加强翻译本科专业的口译能力培养。     

3S技术在国家重点建设工程项目中的应用——以京沪高铁项目(天津段)为例

3S技术是测量技术发展史的一次重大突破,给测量领域带来了新的生命力,并已推广应用在国家基础建设的各个方面。本文以京沪高铁天津段这样的国家重点建设工程项目为例,介绍了3S技术在该项目从土地规划到建设运营方面的应用。     

以马斯洛需求层次理论指导会计职业道德教育

本文提出基于马斯洛需求层次理论,以＂需求实现＂保障会计职业道德教育实效,结合学生的职业生涯发展,以＂需求愿景＂构建会计职业道德约束,并提出系统重构与实施会计专业人才培养方案,为会计职业道德教育提供了新的思路与实践方向。     

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting

Aims: This study compared the risk for major bleeding (MB) and healthcare economic outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with apixaban vs rivaroxaban, dabigatran, or warfarin.

Methods: NVAF patients who initiated apixaban, rivaroxaban, dabigatran, or warfarin were identified from the IMS Pharmetrics Plus database (January 1, 2013–September 30, 2015). Propensity score matching (PSM) was used to balance differences in patient characteristics between study cohorts: patients treated with apixaban vs rivaroxaban, apixaban vs dabigatran, and apixaban vs warfarin. Risk of hospitalization and healthcare costs (all-cause and MB-related) were compared between matched cohorts during the follow-up.

Results: During the follow-up, risks for all-cause (hazard ratio [HR]?=?1.44, 95% confidence interval [CI]?=?1.2–1.7) and MB-related (HR?=?1.57, 95% CI?=?1.0–2.4) hospitalizations were significantly greater for patients treated with rivaroxaban vs apixaban. Adjusted total all-cause healthcare costs were significantly lower for patients treated with apixaban vs rivaroxaban ($3,950 vs $4,333 per patient per month [PPPM], p?=?.002) and MB-related medical costs were not statistically significantly different ($100 vs $233 PPPM, p?=?.096). Risk for all-cause hospitalization (HR?=?1.98, 95% CI?=?1.6–2.4) was significantly greater for patients treated with dabigatran vs apixaban, although total all-cause healthcare costs were not statistically different. Risks for all-cause (HR?=?2.22, 95% CI?=?1.9–2.5) and MB-related (HR?=?2.05, 95% CI?=?1.4–3.0) hospitalizations were significantly greater for patients treated with warfarin vs apixaban. Total all-cause healthcare costs ($3,919 vs $4,177 PPPM, p?=?.025) and MB-related medical costs ($96 vs $212 PPPM, p?=?.026) were significantly lower for patients treated with apixaban vs warfarin.

Limitations: This retrospective database analysis does not establish causation.

Conclusions: In the real-world setting, compared with rivaroxaban and warfarin, apixaban is associated with reduced risk of hospitalization and lower healthcare costs. Compared with dabigatran, apixaban is associated with lower risk of hospitalizations.